Brightspring Health Services, INC 8-K filings

BrightSpring Health Services reported strong second quarter 2026 financial results, with net revenue up 23.0% and Adjusted EBITDA up 44.2%, leading to an increase in full-year guidance.

BrightSpring Health Services, Inc. announced the results of its 2026 Annual Meeting of Stockholders, with all proposals including director elections and auditor ratification receiving strong approval.

BrightSpring Health Services completed the sale of its ResCare Community Living business to Sevita for $835 million, streamlining its focus on core pharmacy and provider services.

BrightSpring Health Services, Inc. announced robust financial results for the fourth quarter and full year ended December 31, 2025, alongside optimistic full-year 2026 guidance.

BrightSpring Health Services reported strong third-quarter 2025 financial results, with significant revenue and Adjusted EBITDA growth, and raised its full-year 2025 revenue guidance.

BrightSpring Health Services' selling stockholders offloaded 15 million common shares in an underwritten offering, while the company concurrently repurchased 1.5 million shares.

BrightSpring Health Services reports strong preliminary third quarter 2025 financial results, including a return to net income and significant revenue growth, leading to increased full-year guidance.

BrightSpring Health Services, Inc. announced robust second-quarter 2025 financial results, driven by significant revenue and Adjusted EBITDA growth, leading to an increase in its full-year 2025 financial guidance.

BrightSpring Health Services, Inc. announced the immediate resignation of Michael McMaude as President of Hospice Services and CEO of Abode Healthcare, Inc., who will transition to a non-employee consulting role with continued equity vesting and restrictive covenants.

BrightSpring Health Services, Inc. announced the closing of an underwritten public offering of 14 million common shares by its selling stockholders, with the company receiving proceeds only from the cash exercise of stock options by management.

BrightSpring Health Services, Inc. has retrospectively revised its financial statements to reflect the divestiture of its Community Living business, showcasing strong revenue growth and substantial debt reduction following its recent IPO.

BrightSpring Health Services, Inc. announced the successful election of two Class I directors, ratification of KPMG LLP as its auditor, and approval of executive compensation at its 2025 Annual Meeting of Stockholders.

BrightSpring Health Services announced positive Q1 2025 financial results, including a 25.9% increase in net revenue and an increase to full year 2025 revenue and Adjusted EBITDA guidance.

BrightSpring Health Services, Inc. discloses the terms of the severance agreement with former CFO Jim Mattingly following his departure in March 2025.

BrightSpring Health Services announces positive Q4 and full year 2024 financial results, including increased revenue and Adjusted EBITDA, and raises its full year 2025 guidance.

BrightSpring Health Services announced the promotion of Jennifer Phipps to Chief Financial Officer, succeeding Jim Mattingly, effective March 4, 2025.

BrightSpring Health Services has entered into an agreement to sell its Community Living business to Sevita for $835 million, focusing on core growth areas and debt reduction.

BrightSpring Health Services successfully refinanced its $2.55 billion Term Loan B facility, reducing the interest rate and generating annual savings.

Matthew D'Ambrosio resigned from BrightSpring Health Services' board and its committees, effective November 12, 2024.

BrightSpring Health Services announced a 28.8% increase in revenue and a significant reduction in net loss for the third quarter of 2024, along with increased full-year guidance.

BrightSpring Health Services' Chief Legal Officer, Steven S. Reed, will retire from his position on October 11, 2024, transitioning to a senior legal counsel role through March 31, 2025.

BrightSpring Health Services has expanded its board of directors by appointing Dr. Steve Miller as a Class II director, effective September 27, 2024.

BrightSpring Health Services announced a 26% increase in revenue and a significant rise in net income for the second quarter of 2024, along with increased full-year guidance.

BrightSpring Health Services will acquire Haven Hospice in Florida, issuing $30 million in company stock as partial consideration.

BrightSpring Health Services has implemented a new cash incentive bonus plan for senior executives, linking payouts to company performance and individual goals.

BrightSpring Health Services announced a 27% increase in first-quarter revenue and raised its full-year 2024 revenue and adjusted EBITDA guidance.

BrightSpring Health Services has increased its board size and appointed Timothy A. Wicks as a new independent director and member of the Audit Committee.

BrightSpring Health Services announced its fourth quarter and full year 2023 financial results, showing revenue growth but also increased net losses, and provided full year 2024 guidance.

BrightSpring Health Services has refinanced $2.566 billion of its existing term loans with new term loans maturing in 2031.

BrightSpring Health Services has entered into a purchase contract agreement with U.S. Bank Trust Company, outlining the terms for its equity-linked securities.